MedTrace Logo

Benefits of Spa Therapy in Saint-Lary Soulan for Knee Osteoarthritis

NCT05790824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2024-08-20

No results posted yet for this study

Summary

The hypothesis is that the use of spa therapy in Saint-Lary Soulan for knee osteoarthritis treatment would have a therapeutic effect on this pathology.

The main objective of this external comparison study is to evaluate the comparative effectiveness at 6 months of spa therapy in the Saint-Lary Soulan spa center on functional disability and pain (MCII: Minimal Clinical Important Improvement) in knee osteoarthritis compared to the control group of the Thermarthrose multicenter randomized clinical trial, receiving standard cares.

The patients included in the Larytherm cohort will undergo a three-week spa therapy in Saint-Lary Soulan with a follow-up of 6 months after the end of spa therapy.

Conditions

Interventions

OTHER

Spa therapy

The "RH2" rheumatology treatment protocol will propose treatments that can be carried out with water from the SL5 borehole and will be composed of: * 54 treatments among the following treatments: * Swimming pool, 15 minutes (code 201) * Bath with aerobath, 10 minutes (code 205) * Bath with immersion shower, 10 minutes (code 206) * Cataplasm in multiple local application, 10 minutes (code 408) * 18 sessions of mobilization pool, 15 minutes (code 601)

Sponsors & Collaborators

  • University of Bordeaux

    lead OTHER

Principal Investigators

  • Patrick Blin · Bordeaux PharmacoEpi

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-01-12
Completion
2024-01-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05790824 on ClinicalTrials.gov